CVE-2006-3571

Public Exploit

Description

Multiple cross-site scripting (XSS) vulnerabilities in interna/hilfe.php in Papoo 3 RC3 and earlier allow remote attackers to inject arbitrary web script or HTML via the (1) titel or (2) ausgabe parameters.

Category

2.6
CVSS
Severity: Low
CVSS 2.0 •
EPSS 8.87% Top 10%
Vendor Advisory secunia.com Vendor Advisory vupen.com
Affected: n/a n/a
Published at:
Updated at:

References

Link Tags
http://www.vupen.com/english/advisories/2006/2713 vdb entry vendor advisory
http://secunia.com/advisories/20978 third party advisory vendor advisory
http://securitytracker.com/id?1016461 vdb entry exploit
http://www.securityfocus.com/bid/18895 vdb entry exploit
http://www.securityfocus.com/archive/1/439518/100/0/threaded mailing list
https://exchange.xforce.ibmcloud.com/vulnerabilities/27639 vdb entry
http://www.osvdb.org/27117 vdb entry
http://securityreason.com/securityalert/1217 third party advisory
https://www.exploit-db.com/exploits/1993 exploit

Frequently Asked Questions

What is the severity of CVE-2006-3571?
CVE-2006-3571 has been scored as a low severity vulnerability.
How to fix CVE-2006-3571?
To fix CVE-2006-3571, make sure you are using an up-to-date version of the affected component(s) by checking the vendor release notes. As for now, there are no other specific guidelines available.
Is CVE-2006-3571 being actively exploited in the wild?
It is possible that CVE-2006-3571 is being exploited or will be exploited in a near future based on public information. According to its EPSS score, there is a ~9% probability that this vulnerability will be exploited by malicious actors in the next 30 days.
This platform uses data from the NIST NVD, MITRE CVE, MITRE CWE, First.org and CISA KEV but is not endorsed or certified by these entities. CVE is a registred trademark of the MITRE Corporation and the authoritative source of CVE content is MITRE's CVE web site. CWE is a registred trademark of the MITRE Corporation and the authoritative source of CWE content is MITRE's CWE web site.
© 2025 Under My Watch. All Rights Reserved.